EcoDrugPlus

Ensembl ID : ENSOMYG00000035700
Gene Symbol: -
Cross references: -
18 Possible Orthologues:

Ensembl ID : ENSOMYG00000036011
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSOMYG00000036157
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSOMYG00000036218
Gene Symbol: -
Cross references: -
188 Possible Orthologues:

Ensembl ID : ENSOMYG00000035397
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSOMYG00000022829
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSOMYG00000037848
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSOMYG00000037965
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSOMYG00000022616
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSOMYG00000022586
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSOMYG00000039888
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSOMYG00000022571
Gene Symbol: -
Cross references: -
170 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).